Up to 11% of US adults are now on GLP-1 medication. That's nearly four times the number from 2024. But the story isn't about people eating less... it's about people eating differently.
In this webinar, Bolt Insight Research Director, Acelya Lokmanhekim, digs into findings from 1,499 US adults across over 2,300 eating occasions to explore what GLP-1 is really doing to snacking behavior.
Food noise is gone, but desire isn't. Consumers are becoming more selective, more intentional and a lot harder to win.
Most brands aren't expecting what the data shows. Watch the recording to find out why, and what it means for your category.
